CPHI Middle East 2026:
CPHI Middle East is an international B2B platform covering the entire pharmaceutical manufacturing and supply chain.
According to forecasts, Saudi Arabia’s pharmaceutical market could reach SAR 67.7 billion by 2028, with a compound annual growth rate of approximately 9.6%.
Key Features
More than 80% of pharmaceutical sales in the region come from imported products, creating significant opportunities for international manufacturers of medicines, ingredients, packaging, equipment and contract services.
74% of CPHI Middle East attendees have purchasing authority, while 44% hold senior positions such as CEO, Chairman, President, Vice President or Director. This enables exhibitors to engage directly with professionals who influence supplier selection and purchasing decisions.
Healthcare expansion and the localisation of pharmaceutical manufacturing are increasing demand for innovative medicines, biotechnology, production equipment, laboratory solutions and drug development services.
CPHI Middle East brings together industry professionals from more than 100 countries, positioning Saudi Arabia as a strategic entry point to the GCC and the wider MENA pharmaceutical market.
Recommendations for Participants
О Profex Group
Profex Group is a leading international partner in organizing and promoting exhibitions across the Middle East, Africa, and Asia. We specialize in providing exhibitors with comprehensive support at every stage of the exhibition process from preparation to post-show services. Our mission is to help companies expand their market presence and build long-term partnerships with key industry players.